Michael Harty (Clare, Independent) | Oireachtas source

This morning we will consider the implications of Brexit for health law in Ireland and the EU with two eminent academics presenting to the committee this morning. On behalf of the committee, I welcome, Professor Imelda Maher, dean of law and professor of European law at the UCD Sutherland School of Law, and Professor Tamara Hervey, Jean Monnet professor of European law at the University of Sheffield in the UK.

I draw the attention of witnesses to the fact that by virtue of section 17(2)(l) of the Defamation Act 2009, they are protected by absolute privilege in respect of their evidence to the committee. However, if they are directed by the committee to cease giving evidence on a particular matter and they continue to so do, they are entitled thereafter only to a qualified privilege in respect of their evidence. They are directed that only evidence connected with the subject matter of these proceedings is to be given and they are asked to respect the parliamentary practice to the effect that, where possible, they should not criticise or make charges against any person, persons or entity by name or in such a way as to make him, her or it identifiable. I also advise witnesses that any opening statements they make may be published on the committee's website after the meeting.

Members are reminded of the long-standing parliamentary practice to the effect that they should not comment on, criticise or make charges against a person outside the House or an official either by name or in such a way as to make him or her identifiable.

I ask Professor Maher to make her opening statement.